(S1 (S (S (NP (NN Glioma) (NN tumor) (JJ stem-like) (NNS cells)) (VP (VBP promote) (NP (NP (NN tumor) (NN angiogenesis)) (CC and) (NP (NN vasculogenesis))) (PP (IN via) (NP (NP (JJ vascular) (JJ endothelial) (NN growth) (NN factor)) (CC and) (NP (JJ stromal-derived) (NN factor) (CD 1)))))) (. .)))
(S1 (S (S (NP (NP (NN Cancer) (NN stem) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN CSC)) (-RRB- -RRB-))) (VP (VBP are) (VP (VBN predicted) (S (VP (TO to) (VP (VB be) (NP (NP (JJ critical) (NNS drivers)) (PP (IN of) (NP (NN tumor) (NN progression)))) (PP (JJ due) (TO to) (NP (NP (PRP$ their) (JJ self-renewal) (NN capacity)) (CC and) (NP (NN limitless) (JJ proliferative) (NN potential)))))))))) (. .)))
(S1 (S (S (NP (NP (DT An) (VBG emerging) (NN area)) (PP (IN of) (NP (NN research)))) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NN CSC)) (VP (MD may) (ADVP (RB also)) (VP (VBP support) (NP (NN tumor) (NN progression)) (PP (IN by) (S (VP (VBG promoting) (NP (NN tumor) (NN angiogenesis))))))))))) (. .)))
(S1 (S (S (S (VP (TO To) (VP (VB investigate) (SBAR (WHADVP (WRB how)) (S (NP (NN CSC)) (VP (VBP contribute) (PP (TO to) (NP (NN tumor) (JJ vascular) (NN development))))))))) (, ,) (NP (PRP we)) (VP (VBD used) (NP (DT an) (NN approach)) (S (VP (VBG comparing) (NP (NP (NN tumor) (NNS xenografts)) (PP (IN of) (NP (NP (DT the) (JJ C6) (NN glioma) (NN cell) (NN line)) (VP (VBG containing) (NP (CC either) (NP (DT a) (JJ low)) (CC or) (NP (NP (DT a) (JJ high) (NN fraction)) (PP (IN of) (NP (NN CSC))))))))))))) (. .)))
(S1 (S (PP (VBN Compared) (PP (IN with) (NP (JJ CSC-low) (NNS tumors)))) (, ,) (NP (NN CSC-high) (NNS tumors)) (VP (VP (VBD exhibited) (NP (NP (VBN increased) (NN microvessel) (NN density)) (CC and) (NP (NN blood) (NN perfusion)))) (CC and) (VP (VBD induced) (NP (NP (VBN increased) (NN mobilization)) (CC and) (NP (NP (NN tumor) (NN recruitment)) (PP (IN of) (NP (NP (NN bone) (JJ marrow-derived) (JJ endothelial) (NN progenitor) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN EPC)) (-RRB- -RRB-)))))))) (. .)))
(S1 (S (S (NP (JJ CSC-high) (NN C6) (NN cell) (NNS cultures)) (ADVP (RB also)) (VP (VBD induced) (NP (NP (JJR higher) (NNS levels)) (PP (IN of) (NP (NP (JJ endothelial) (NN cell) (NN proliferation)) (CC and) (NP (NN tubule) (NN organization))))) (ADVP (FW in) (FW vitro)) (PP (VBN compared) (PP (IN with) (NP (JJ CSC-low) (NNS cultures)))))) (. .)))
(S1 (S (S (S (NP (NP (JJ CSC-high) (NNS cultures)) (CC and) (NP (NNS tumors))) (VP (VBD expressed) (NP (NP (VBN increased) (NNS levels)) (PP (IN of) (NP (NP (DT the) (JJ proangiogenic) (NNS factors)) (NP (NP (JJ vascular) (JJ endothelial) (NN growth) (NN factor)) (CC and) (NP (JJ stromal-derived) (NN factor) (CD 1)))))))) (, ,) (CC and) (S (SBAR (WHADVP (WRB when)) (S (NP (NP (NN signaling)) (PP (IN by) (NP (DT either) (NN factor)))) (VP (VBD was) (VP (VBN blocked))))) (, ,) (NP (NP (DT all) (NNS aspects)) (PP (IN of) (NP (NP (NN angiogenesis)) (VP (VBN observed) (PP (IN in) (NP (NP (JJ CSC-high) (NNS cultures)) (CC and) (NP (NNS tumors))))))) (, ,) (PP (VBG including) (NP (NP (NN microvessel) (NN density)) (, ,) (NP (NN perfusion)) (, ,) (NP (NN EPC) (NN mobilization/recruitment)) (, ,) (CC and) (NP (NP (NN stimulation)) (PP (IN of) (NP (NP (JJ endothelial) (NN cell)) (NN activity)))))) (, ,)) (VP (VBD were) (VP (VBN reduced) (PP (TO to) (NP (NP (NNS levels)) (ADJP (JJ comparable) (PP (IN with) (NP (NP (DT those)) (VP (VBN observed) (PP (IN in) (NP (JJ CSC-low) (NNS cultures/tumors))))))))))))) (. .)))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN CSC)) (VP (VBP contribute) (PP (TO to) (NP (NN tumor) (NN angiogenesis))) (PP (IN by) (S (VP (VBG promoting) (NP (CC both) (NP (JJ local) (JJ endothelial) (NN cell) (NN activity)) (CC and) (NP (NP (JJ systemic) (JJ angiogenic) (NNS processes)) (VP (VBG involving) (NP (ADJP (NN bone) (JJ marrow-derived)) (NN EPC))))) (PP (IN in) (NP (NP (DT a) (JJ vascular) (JJ endothelial) (NN growth) (JJ factor-dependent) (CC and) (JJ stromal-derived) (NN factor)) (JJ 1-dependent) (NN manner))))))))))) (. .)))
